We were delighted to join MORPh, the UK’s largest free clinical training provider, as guest speakers at its Bristol event, “Neurodiversity & Mental Health in Primary Care: ADHD, Depression, Anxiety & Behaviour Change.”

The event brought together primary care pharmacists and GPs from across the country for a day of learning, discussion and practical insight, with strong engagement throughout the programme.

Our Director of Clinical Research & Neurodevelopmental Services delivered an insightful session focused on ADHD and neurodevelopmental services, exploring the practical considerations healthcare professionals face when supporting adults with ADHD in primary care.

Supporting adults with ADHD in primary care

The session provided an overview of the adult ADHD pathway, from referral and diagnostic assessment through to medication titration and shared care.

Key areas discussed included:

• Understanding the adult ADHD pathway, including referral, diagnostic assessment, medication titration and shared-care arrangements.
• Recognising effective shared care, including when healthcare professionals may need to clarify or challenge existing arrangements.
• Taking a whole-person approach to ADHD care, combining medicines optimisation with practical signposting and appropriate non-pharmacological support.
• Responding safely to clinical challenges, including monitoring abnormalities, medication supply disruptions and requests for treatment changes.
• Building ADHD and neurodiversity capability within primary care, with practical approaches for developing confidence across Primary Care Networks (PCNs) and multidisciplinary teams (MDTs).

Promoting person-centred ADHD care

A key theme throughout the session was the importance of confident, collaborative and person-centred care.

Effective ADHD support involves more than medication management. Healthcare professionals also need to consider the individual's wider needs and ensure they receive appropriate information, support and signposting throughout their care.

The session explored how primary care teams can navigate the complexities of ADHD services while keeping the individual at the heart of clinical decision-making.

Building confidence in neurodevelopmental care

Events such as the MORPh Bristol session provide an important opportunity for healthcare professionals to share knowledge, discuss real-world challenges and develop their confidence in supporting people with neurodevelopmental conditions.

With growing awareness of ADHD and neurodiversity across healthcare, ongoing education can help primary care professionals better understand referral pathways, shared-care responsibilities, medicines optimisation and the wider support available to patients.

We would like to thank MORPh for the invitation and for creating opportunities for clinicians to strengthen their knowledge and confidence in neurodevelopmental and mental health care.

It was a pleasure to contribute to a day that brought together primary care pharmacists and GP colleagues from across the country for meaningful learning and discussion.